You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-EXEL-0346
EXEL-0346

Chemical Structure : EXEL-0346

CAS No.: 1239893-96-9

EXEL-0346 (EXEL0346)

Catalog No.: PC-61427Not For Human Use, Lab Use Only.

EXEL-0346 (EXEL0346) is a novel potent, orally active Glucosylceramide synthase (GCS) inhibitor with IC50 of 2 nM.

Packing Price Stock Quantity
100 mg Get quote
250 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

EXEL-0346 (EXEL0346) is a novel potent, orally active Glucosylceramide synthase (GCS) inhibitor with IC50 of 2 nM.
EXEL-0346 decreases glucosylceramide synthesis and ganglioside GM1 synthesis in A549 cells with IC50 of 15 nM.
EXEL-0346 robustly improves glucose tolerance in diet induced obese mice and ZDF rats, decreases plasma triglycerides and reduces hepatic fat deposition.
EXEL-0346 exhibits excellent oral bioavailability coupled with the long half-life.

Physicochemical Properties

M.Wt 580.446
Formula C27H29BrF3N3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-[(1S)-2-(3-Amino-8-azabicyclo[3.2.1]oct-8-yl)-1-[(4-bromophenyl)methyl]-2-oxoethyl]-1-[4-[(trifluoromethyl)oxy]-phenyl]cyclopropanecarboxamide

References

1. Richards S, et al. J Med Chem. 2012 May 10;55(9):4322-35.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: